Hypertension Research Today is a free monthly online journal that collates and summarizes the latest research about Hypertension, including details on symptoms, diagnosis, diet, treatment, causes.

Volume 5 (2008), Issue 11 (November)

1. Best-practice interventions to reduce socioeconomic inequalities of coronary heart disease mortality in UK: a prospective occupational cohort study.
   Lancet, 372(9650): 1648-54. [Abstract] [Full-text]
2. Emergence of chronic non-communicable diseases in China.
   Lancet, 372(9650): 1697-705. [Abstract] [Full-text]
3. Echocardiographic and clinical risk factors for atrial fibrillation in hypertensive patients with ischemic stroke.
   Am J Cardiol, 102(10): 1348-51. [Abstract] [Full-text]
4. beta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in hypertension.
   Clin Pharmacol Ther, 84(6): 715-21. [Abstract] [Full-text]
5. Helicobacter pylori infection and arterial stiffness in patients with type 2 diabetes mellitus.
   Metabolism, 57(12): 1760-4. [Abstract] [Full-text]
6. Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertension.
   PLoS ONE, 3(11): e3742. [Abstract] [Full-text]
7. Collectrin is involved in the development of salt-sensitive hypertension by facilitating the membrane trafficking of apical membrane proteins via interaction with soluble N-ethylmaleiamide-sensitive factor attachment protein receptor complex.
   Circulation, 118(21): 2146-55. [Abstract] [Full-text]
8. Resistant hypertension: an overview of evaluation and treatment.
   J Am Coll Cardiol, 52(22): 1749-57. [Abstract] [Full-text]
9. Determinants of the ambulatory arterial stiffness index in 7604 subjects from 6 populations.
   Hypertension, 52(6): 1038-44. [Abstract] [Full-text]
10. Angiotensin II-dependent hypertension increases Na transport-related oxygen consumption by the thick ascending limb.
    Hypertension, 52(6): 1091-8. [Abstract] [Full-text]
11. Effects of telmisartan and ramipril on adiponectin and blood pressure in patients with type 2 diabetes.
    Am J Hypertens, 21(12): 1330-6. [Abstract] [Full-text]
12. Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama study.
    Hypertension, 52(6): 1045-50. [Abstract] [Full-text]
13. Exogenous L-arginine ameliorates angiotensin II-induced hypertension and renal damage in rats.
    Hypertension, 52(6): 1084-90. [Abstract] [Full-text]
14. Cross-talk between mineralocorticoid and angiotensin II signaling for cardiac remodeling.
    Hypertension, 52(6): 1060-7. [Abstract] [Full-text]
15. Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study.
    Hypertension, 52(6): 1030-7. [Abstract] [Full-text]
16. Changes in serum potassium mediate thiazide-induced diabetes.
    Hypertension, 52(6): 1022-9. [Abstract] [Full-text]
17. Brain imaging findings predict blood pressure response to pharmacological treatment.
    Hypertension, 52(6): 1113-9. [Abstract] [Full-text]
18. Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade.
    Hypertension, 52(6): 1161-7. [Abstract] [Full-text]
19. Dietary salt activates an endothelial proline-rich tyrosine kinase 2/c-Src/phosphatidylinositol 3-kinase complex to promote endothelial nitric oxide synthase phosphorylation.
    Hypertension, 52(6): 1134-41. [Abstract] [Full-text]
20. Renin inhibition improves cardiac function and remodeling after myocardial infarction independent of blood pressure.
    Hypertension, 52(6): 1068-75. [Abstract] [Full-text]
21. Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptor-nitric oxide signaling.
    Hypertension, 52(6): 1099-105. [Abstract] [Full-text]
22. Deletion of WNK1 first intron results in misregulation of both isoforms in renal and extrarenal tissues.
    Hypertension, 52(6): 1149-54. [Abstract] [Full-text]
23. Relationship of plasma renin with a prothrombotic state in hypertension: relevance for organ damage.
    Am J Hypertens, 21(12): 1347-53. [Abstract] [Full-text]
24. A polymorphism regulates CYP4A11 transcriptional activity and is associated with hypertension in a Japanese population.
    Hypertension, 52(6): 1142-8. [Abstract] [Full-text]
25. Patients with renal dysfunction require a longer duration until blood pressure dips during the night.
    Hypertension, 52(6): 1155-60. [Abstract] [Full-text]
26. Influence of gender on the association of alcohol drinking with blood pressure.
    Am J Hypertens, 21(12): 1310-7. [Abstract] [Full-text]
27. Increased aortic pulse wave velocity is associated with silent cerebral small-vessel disease in hypertensive patients.
    Hypertension, 52(6): 1120-6. [Abstract] [Full-text]
28. Endogenous nitric oxide synthase inhibitors, arterial hemodynamics, and subclinical vascular disease: the PREVENCION Study.
    Hypertension, 52(6): 1051-9. [Abstract] [Full-text]
29. Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats.
    Hypertension, 52(6): 1168-72. [Abstract] [Full-text]
30. Von Willebrand factor as marker of vascular function in South African women: the POWIRS Study.
    Am J Hypertens, 21(12): 1298-303. [Abstract] [Full-text]
31. Association between pulse pressure and 30-month all-cause mortality in peritoneal dialysis patients.
    Am J Hypertens, 21(12): 1318-23. [Abstract] [Full-text]
32. Abnormal glucose metabolism in hypertensive mice with genetically interrupted gamma-melanocyte stimulating hormone signaling fed a high-sodium diet.
    Am J Hypertens, 21(12): 1284-7. [Abstract] [Full-text]
33. A comparative analysis of four clinical guidelines for hypertension management.
    J Hum Hypertens, 22(12): 829-37. [Abstract] [Full-text]
34. Epicardial adipose tissue expression of adiponectin is lower in patients with hypertension.
    J Hum Hypertens, 22(12): 856-63. [Abstract] [Full-text]
35. The pressure of finding human hypertension genes: new tools, old dilemmas.
    J Hum Hypertens, 22(12): 821-8. [Abstract] [Full-text]
36. Cost-effectiveness of irbesartan/hydrochlorothiazide in patients with hypertension: an economic evaluation for Sweden.
    J Hum Hypertens, 22(12): 845-55. [Abstract] [Full-text]
37. Central blood pressure measurement may improve risk stratification.
    J Hum Hypertens, 22(12): 838-44. [Abstract] [Full-text]
38. Hypertension as part of the metabolic syndrome.
    J Hum Hypertens, 22(12): 871-4. [Abstract] [Full-text]
39. Relaxation therapies for the management of primary hypertension in adults: a Cochrane review.
    J Hum Hypertens, 22(12): 809-20. [Abstract] [Full-text]
40. Replication of the Wellcome Trust genome-wide association study of essential hypertension: the Family Blood Pressure Program.
    Eur J Hum Genet, 16(12): 1507-11. [Abstract] [Full-text]
41. Aspects of intracerebral hematomas--an update.
    Acta Neurol Scand, 118(6): 347-61. [Abstract] [Full-text]
42. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN).
    Arch Intern Med, 168(21): 2355-61. [Abstract] [Full-text]
43. Prognostic influence of office and ambulatory blood pressures in resistant hypertension.
    Arch Intern Med, 168(21): 2340-6. [Abstract] [Full-text]
44. Gender differences in office and ambulatory control of hypertension.
    Am J Med, 121(12): 1078-84. [Abstract] [Full-text]
45. Comparison of cardiovascular risk factors for high brachial pulse pressure in blacks versus whites (Charleston Heart Study, Evans County Study, NHANES I and II Studies).
    Am J Cardiol, 102(11): 1514-7. [Abstract] [Full-text]
46. Measuring blood pressure knowledge and self-care behaviors of African Americans.
    Res Nurs Health, 31(6): 543-52. [Abstract] [Full-text]
47. Cadmium in blood and hypertension.
    Sci Total Environ, 407(1): 147-53. [Abstract] [Full-text]
48. Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension.
    Am Heart J, 156(6): 1154.e1-8. [Abstract] [Full-text]
49. Tobacco smoking, body mass index, hypertension, and kidney cancer risk in central and eastern Europe.
    Br J Cancer, 99(11): 1912-5. [Abstract] [Full-text]
50. Management of hypertensive emergencies in acute brain disease: evaluation of the treatment effects of intravenous nicardipine on cerebral oxygenation.
    J Neurosurg, 109(6): 1065-74. [Abstract] [Full-text]

© 2004-2010 Hypertension Research Today. All Rights Reserved.